Home Clot risk in Lilly lung-cancer drug raises FDA concerns
 

Keywords :   


Clot risk in Lilly lung-cancer drug raises FDA concerns

2015-07-07 21:33:35| Biotech - Topix.net

Eli Lilly and Co.' s experimental lung cancer drug has raised concerns with U.S. regulators that it may increase patients' risk of suffering potentially deadly blood clots.

Tags: risk drug concerns raises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Atlantic Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
More »